Written question asked by Simon Burns (Conservative) on Monday, 20 February 2017, in the House of Commons. It was due for an answer on Thursday, 23 February 2017 (named day). It was answered by Baroness Blackwood of North Oxford (Conservative) on Thursday, 23 February 2017 on behalf of the Department of Health.
Palbociclib
- Question
-
To ask the Secretary of State for Health, what meetings representatives from NICE (a) have had and (b) plan to have with Pfizer during the consultation period for palbociclib (Ibrance) since the publication of the draft guidance on that drug on 3 February 2017.
- Answer
-
The National Institute for Health and Care Excellence has advised that a meeting with Pfizer to discuss the appraisal of palbociclib took place on 22 February 2017.
Secondary information
- Type
- Written question
- Reference
- 64599
- Session
- 2016-17
- Subjects
- National Institute for Health and Care Excellence Pfizer Palbociclib
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2017-03-09 21:06:47 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/64599
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/64599
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/64599